Morphic Therapeutic's Series A Round

Morphic Therapeutic raised a round of funding on June 30, 2016.

Morphic Therapeutic is developing a new generation of oral integrin therapies for immunological, fibrotic, neoplastic and vascular diseases.…

Articles about Morphic Therapeutic's Series A Round: